A/DT
Comparative/JJ
Analysis/NN
of/IN
Monofunctional/JJ
Biosynthetic/JJ
Peptidoglycan/NN
Transglycosylase/NN
(/(
MBPT/NN
)/)
from/IN
Pathogenic/JJ
and/CC
Non-pathogenic/JJ
Bacteria/NN
./.
====================
Monofunctional/JJ
biosynthetic/JJ
peptidoglycan/NN
transglycosylase/NN
(/(
MBPT/NN
)/)
catalyzes/VBZ
the/DT
formation/NN
of/IN
the/DT
glycan/NN
chain/NN
in/IN
bacterial/JJ
cell/NN
walls/NNS
from/IN
peptidoglycan/NN
subunits/NNS
:/:
N-acetylglucosamine/NN
(/(
NAG/NN
)/)
and/CC
acetylmuramic/JJ
acid/NN
(/(
NAM/NN
)/)
./.
====================
Bifunctional/JJ
glycosyltransferases/NNS
such/JJ
as/IN
the/DT
penicillin/NN
binding/VBG
protein/NN
(/(
PBP/NN
)/)
have/VBP
peptidoglycan/NN
glycosyltransferase/NN
(/(
PGT/NN
)/)
on/IN
their/PRP$
C/NN
terminal/JJ
end/NN
which/WDT
links/VBZ
together/RB
the/DT
peptidoglycan/NN
subunits/NNS
while/IN
transpeptidase/NN
(/(
TP/NN
)/)
on/IN
the/DT
N/NN
terminal/JJ
end/NN
crosslinks/NNS
the/DT
peptide/NN
moieties/NNS
on/IN
the/DT
NAM/NN
monosaccharide/NN
of/IN
the/DT
peptide/NN
subunits/NNS
to/TO
create/VB
the/DT
bacterial/JJ
cell/NN
wall/NN
./.
====================
The/DT
singular/JJ
function/NN
of/IN
MBPT/NN
resembles/NNS
the/DT
C/NN
terminal/JJ
end/NN
of/IN
PBP/NN
as/IN
it/PRP
too/RB
contains/VBZ
and/CC
utilizes/VBZ
a/DT
similar/JJ
PGT/NN
domain/NN
./.
====================
In/IN
this/DT
article/NN
we/PRP
analyzed/VBD
the/DT
infectious/JJ
and/CC
non/JJ
infectious/JJ
protein/NN
sequences/NNS
of/IN
MBPT/NN
from/IN
31/CD
different/JJ
strains/NNS
of/IN
bacteria/NNS
using/VBG
a/DT
variety/NN
of/IN
bioinformatic/JJ
tools/NNS
./.
====================
Motif/DT
analysis/NN
,/,
dot-plot/JJ
comparison/NN
,/,
and/CC
phylogenetic/JJ
analysis/NN
identified/VBD
a/DT
number/NN
of/IN
significant/JJ
differences/NNS
between/IN
infectious/JJ
and/CC
non-infectious/JJ
protein/NN
sequences/NNS
./.
====================
In/IN
this/DT
paper/NN
we/PRP
have/VBP
made/VBN
an/DT
attempt/NN
to/TO
explain/VB
,/,
analyze/VB
and/CC
discuss/VBP
these/DT
differences/NNS
from/IN
an/DT
evolutionary/JJ
perspective/JJ
./.
====================
The/DT
results/NNS
of/IN
our/PRP$
sequence/NN
analysis/NN
may/MD
open/VB
the/DT
door/JJ
for/IN
utilizing/VBG
MBPT/NN
as/IN
a/DT
new/JJ
target/NN
to/TO
fight/CD
a/DT
variety/NN
of/IN
infectious/JJ
bacteria/NNS
./.
====================
Monofunctional/JJ
biosynthetic/JJ
peptidoglycan/NN
transglycosylase/NN
is/VBZ
a/DT
member/NN
of/IN
Glycosyltransferase/NN
Family/RB
51/CD
and/CC
present/JJ
in/IN
over/IN
3000/CD
bacterial/JJ
species/NNS
as/IN
well/RB
as/IN
three/CD
eukaryotic/JJ
species/NNS
:/:
moss/RBR
,/,
green/VBN
algae/RB
,/,
and/CC
ameboid/JJ
(/(
Sauvage/NN
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
As/IN
its/PRP$
name/NN
suggests/VBZ
,/,
the/DT
protein/NN
is/VBZ
involved/VBN
in/IN
the/DT
process/NN
of/IN
peptidoglycan/NN
synthesis/NN
by/IN
catalyzing/VBG
the/DT
formation/NN
of/IN
glycan/NN
chains/NNS
(/(
Yuan/NN
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
The/DT
Glycosyltransferase/NN
,/,
GT/NN
,/,
family/NN
can/MD
be/VB
divided/VBN
into/IN
two/CD
categories/NNS
:/:
monofunctional/JJ
GT/NN
and/CC
bifunctional/JJ
GT/NN
which/WDT
has/VBZ
a/DT
glycosyltransferase/NN
domain/NN
as/IN
well/RB
as/IN
transpeptidase/JJ
domain/NN
(/(
Terrak/NN
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
The/DT
bifunctional/JJ
GT/NN
class/NN
has/VBZ
been/VBN
thoroughly/RB
studied/VBN
as/IN
a/DT
target/NN
of/IN
antibiotics/NNS
as/IN
penicillin/NN
is/VBZ
known/VBN
to/TO
bind/VB
to/TO
the/DT
transpeptidase/NN
domain/NN
of/IN
the/DT
bifunctional/JJ
GT/NN
or/CC
the/DT
penicillinbinding/NN
protein/NN
(/(
Berardino/NN
,/,
1996/CD
;/:
Barrett/NN
,/,
2007/CD
)/)
./.
====================
Monofunctional/JJ
biosynthetic/JJ
peptidoglycan/NN
transglycosylase/NN
polymerizes/VBZ
disaccharide/NN
units/NNS
to/TO
form/VB
glycan/NN
chains/NNS
,/,
which/WDT
are/VBP
crosslinked/VBN
by/IN
transpeptidase/JJ
to/TO
build/JJ
the/DT
peptidoglycan/NN
walls/NNS
of/IN
the/DT
bacterial/JJ
cell/NN
(/(
Berardino/NN
et/FW
al./FW
,/,
1996/CD
;/:
Terrak/NN
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
MBPT/NN
catalyzes/VBZ
the/DT
formation/NN
of/IN
peptidoglycan/NN
subunits/NNS
which/WDT
consist/VBP
of/IN
two/CD
monosaccharides/NNS
:/:
Nacetylglucosamine/NN
(/(
NAG/NN
or/CC
GlcNAc/JJ
)/)
and/CC
Nacetylmuramic/JJ
acid/NN
(/(
NAM/NN
or/CC
MurNAc/JJ
)/)
,/,
that/DT
are/VBP
connected/VBN
by/IN
a/DT
β/JJ
(/(
1,4/CD
)/)
glycosydic/JJ
bond/NN
(/(
Terrak/NN
et/FW
al./FW
,/,
2008/CD
)/)
(/(
Fig/NN
./.
====================
1/CD
)/)
./.
====================
The/DT
NAM/NN
monosaccharide/NN
has/VBZ
two/CD
different/JJ
peptide/NN
moieties/NNS
which/WDT
are/VBP
crosslinked/VBN
by/IN
the/DT
transpeptidase/JJ
enzyme/NN
on/IN
the/DT
C/NN
terminal/JJ
end/NN
of/IN
the/DT
PBP/NN
enzyme/NN
or/CC
by/IN
a/DT
monofunctional/JJ
transpeptidase/NN
protein/NN
such/JJ
as/IN
DDtranspeptidase/JJ
,/,
DDcarboxypeptidase/NN
,/,
and/CC
DDendopeptidase/NN
(/(
Ghuysen/NNP
et/FW
al./FW
,/,
1998/CD
;/:
Yuan/NNP
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
The/DT
NAM/NN
peptide/NN
chain/NN
containing/VBG
Dalanine/NN
,/,
Dglutamic/JJ
acid/NN
,/,
and/CC
mesodiaminopimelic/JJ
acid/NN
is/VBZ
present/JJ
in/IN
the/DT
thinner/NN
cell/NN
walled/JJ
,/,
gram/NN
negative/JJ
bacteria/NNS
such/JJ
as/IN
Hemophilus/JJ
influenza/NN
./.
====================
Gram/NN
positive/JJ
bacteria/NNS
such/JJ
as/IN
Staphylococcus/FW
aureus/FW
have/VBP
a/DT
thicker/NN
cell/NN
wall/NN
as/IN
the/DT
peptide/NN
sequence/NN
is/VBZ
:/:
Lalanine/JJ
,/,
Dglutamine/NN
,/,
Llysine/NN
,/,
and/CC
Dalanine/NN
./.
====================
MBPT/NN
links/NNS
the/DT
nucleophilic/JJ
hydroxyl/NN
group/NN
on/IN
the/DT
fourth/JJ
carbon/JJ
of/IN
the/DT
NAG/NN
moiety/NN
to/TO
the/DT
electrophilic/JJ
carbon/JJ
with/IN
the/DT
protruding/VBG
diphospholipid/JJ
chain/NN
of/IN
the/DT
NAM/NN
moiety/NN
(/(
Yuan/NNP
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
An/DT
over/IN
expression/NN
of/IN
the/DT
MBPT/NN
gene/NN
,/,
mgt/RB
,/,
causes/VBZ
an/DT
increase/NN
in/IN
the/DT
formation/NN
of/IN
the/DT
peptidoglycan/NN
subunits/NNS
,/,
in/IN
vitro/FW
,/,
as/IN
further/RB
work/NN
can/MD
be/VB
done/VBN
to/TO
analyze/VB
the/DT
precise/JJ
lengths/NNS
of/IN
the/DT
glycan/NN
chain/NN
created/VBD
by/IN
monofunctional/JJ
and/CC
bifunctional/JJ
transpeptidase/NN
which/WDT
may/MD
infer/VB
further/RB
differences/NNS
between/IN
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
(/(
Di/NNP
Berardino/NN
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
The/DT
generation/NN
of/IN
MBPT/NN
from/IN
the/DT
mgt/NN
gene/NN
also/RB
gives/VBZ
MBPT/NN
its/PRP$
own/JJ
identity/NN
separate/JJ
from/IN
the/DT
bi/NN
functional/JJ
PBP/NN
which/WDT
is/VBZ
transcribed/VBN
from/IN
the/DT
pbp/JJ
gene/NN
even/RB
though/IN
both/DT
enzymes/NNS
share/VBP
a/DT
great/JJ
deal/JJ
of/IN
homology/NN
in/IN
their/PRP$
respective/JJ
PGT/NN
domains/NNS
(/(
Barrett/NN
,/,
2007/CD
;/:
DiBerardi/NNP
et/FW
al./FW
,/,
1996/CD
;/:
Paik/NN
et/FW
al./FW
,/,
1997/CD
;/:
Spratt/NN
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
Bioinformatic/JJ
analysis/NN
of/IN
the/DT
monofunctional/JJ
transpeptidase/NN
protein/NN
may/MD
provide/VB
further/JJ
insight/NN
into/IN
the/DT
actions/NNS
of/IN
infectious/JJ
bacteria/NNS
especially/RB
in/IN
comparison/NN
to/TO
MBPT/NN
and/CC
PBP/NN
./.
====================
The/DT
precise/JJ
role/NN
of/IN
each/DT
peptidoglycan/NN
synthesizing/VBG
enzyme/NN
is/VBZ
still/RB
unknown/JJ
as/IN
it/PRP
is/VBZ
possible/JJ
that/IN
the/DT
biosynthesis/NN
,/,
repair/NN
,/,
and/CC
upkeep/IN
of/IN
the/DT
cell/NN
wall/NN
is/VBZ
so/RB
vital/JJ
that/DT
each/DT
enzyme/NN
may/MD
be/VB
called/VBN
upon/IN
for/IN
a/DT
different/JJ
reason/NN
be/VB
it/PRP
synthesizing/VBG
a/DT
new/JJ
cell/NN
wall/NN
,/,
repairing/VBG
the/DT
cell/NN
wall/NN
,/,
or/CC
fixing/JJ
mistakes/VBZ
in/IN
the/DT
structure/NN
of/IN
the/DT
cell/NN
wall/NN
all/DT
of/IN
which/WDT
are/VBP
similar/JJ
to/TO
the/DT
role/NN
of/IN
polymerases/NNS
in/IN
DNA/NN
construction/NN
./.
====================
Though/IN
the/DT
two/CD
proteins/NNS
have/VBP
similar/JJ
roles/NNS
,/,
structures/NNS
,/,
and/CC
domains/NNS
(/(
PGT/NN
)/)
,/,
MBPT/NN
is/VBZ
present/JJ
in/IN
a/DT
great/JJ
many/JJ
more/RBR
bacteria/NNS
than/IN
PBP/NN
with/IN
a/DT
wide/JJ
variety/NN
of/IN
habitats/NNS
as/IN
well/RB
as/IN
forms/VBZ
of/IN
infection/NN
suggesting/VBG
that/IN
MBPT/NN
may/MD
play/VB
a/DT
key/JJ
role/NN
in/IN
the/DT
biosynthesis/NN
of/IN
the/DT
cell/NN
wall/NN
in/IN
a/DT
majority/NN
of/IN
bacteria/NNS
and/CC
a/DT
new/JJ
source/NN
of/IN
differentiation/NN
in/IN
the/DT
pathology/NN
of/IN
bacteria/NNS
./.
====================
Bacterial/JJ
pathogenicity/NN
has/VBZ
been/VBN
one/CD
of/IN
the/DT
highly/RB
studied/VBN
fields/NNS
for/IN
obvious/JJ
reasons/NNS
and/CC
has/VBZ
lead/RB
to/TO
the/DT
identification/NN
of/IN
a/DT
variety/NN
of/IN
virulence/NN
factors/NNS
such/JJ
as/IN
adhesion/NN
molecules/NNS
,/,
metabolic/JJ
enzymes/NNS
,/,
and/CC
toxins/NNS
,/,
which/WDT
take/VBP
advantage/NN
of/IN
a/DT
host/NN
’/NN
s/NNS
resources/VBZ
to/TO
allow/VB
the/DT
infectious/JJ
bacteria/NNS
to/TO
multiply/RB
and/CC
spread/RB
(/(
Yang/NNP
et/FW
al./FW
,/,
2008/CD
)/)
./.
====================
The/DT
degree/NN
of/IN
infection/NN
and/CC
its/PRP$
aggressiveness/NN
can/MD
be/VB
defined/VBN
by/IN
the/DT
infectious/JJ
bacteria/NNS
’/CD
s/NNS
virulence/NN
which/WDT
gages/VBZ
the/DT
potency/NN
of/IN
an/DT
infectious/JJ
agent/NN
based/VBN
on/IN
its/PRP$
ability/NN
to/TO
invade/VB
the/DT
host/NN
’/NN
s/NNS
system/NN
and/CC
induce/VBP
disease/NN
./.
====================
An/DT
infectious/JJ
agent/NN
has/VBZ
to/TO
be/VB
able/JJ
to/TO
penetrate/VB
the/DT
host/NN
’/NN
s/NNS
immune/JJ
system/NN
and/CC
find/VBP
an/DT
area/NN
in/IN
the/DT
host/NN
to/TO
multiply/RB
which/WDT
is/VBZ
predicated/VBN
on/IN
the/DT
infectious/JJ
bacteria/NNS
’/CD
s/NNS
mode/NN
of/IN
conveyance/NN
as/IN
well/RB
as/IN
the/DT
makeup/JJ
of/IN
the/DT
cell/NN
’/NN
s/NNS
surface/NN
./.
====================
The/DT
role/NN
of/IN
PBP/NN
has/VBZ
been/VBN
deeply/RB
studied/VBN
as/IN
it/PRP
has/VBZ
been/VBN
traditionally/RB
targeted/VBN
by/IN
a/DT
variety/NN
of/IN
antibiotics/NNS
giving/VBG
it/PRP
the/DT
name/NN
,/,
penicillin/NN
binding/VBG
protein/NN
(/(
Suginaka/NN
et/FW
al./FW
,/,
2007/CD
)/)
./.
====================
A/DT
number/NN
of/IN
sequenced/VBN
genomes/NNS
from/IN
a/DT
variety/NN
of/IN
bacterial/JJ
species/NNS
indicate/VBP
that/IN
a/DT
majority/NN
of/IN
bacterial/JJ
species/NNS
have/VBP
acquired/VBN
genes/NNS
via/IN
horizontal/JJ
gene/NN
transfer/NN
which/WDT
allows/VBZ
them/PRP
to/TO
be/VB
better/RBR
suited/JJ
to/TO
survive/VB
in/IN
certain/JJ
environmental/JJ
conditions/NNS
or/CC
niches/NNS
(/(
Schmidt/NNP
and/CC
Hensel/JJ
,/,
2004/CD
)/)
./.
====================
Horizontal/JJ
gene/NN
transfer/NN
can/MD
be/VB
achieved/VBN
through/IN
a/DT
variety/NN
of/IN
mechanisms/NNS
including/VBG
natural/JJ
transformation/NN
(/(
Schmidt/NNP
and/CC
Hensel/JJ
,/,
2004/CD
)/)
,/,
an/DT
exchange/NN
of/IN
plasmids/NNS
and/CC
pathogenicity/NN
islands/VBZ
by/IN
way/NN
of/IN
conjugation/NN
(/(
Schierack/NNP
et/FW
al./FW
,/,
2006/CD
)/)
as/IN
well/RB
as/IN
transduction/NN
by/IN
bacteriophages/NNS
(/(
Wagner/NN
and/CC
Waldor/NN
,/,
2002/CD
)/)
./.
====================
Evolutionary/RB
differences/NNS
between/IN
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
are/VBP
apparent/JJ
in/IN
their/PRP$
protein/NN
sequences/NNS
as/IN
the/DT
two/CD
factions/NNS
continue/VB
to/TO
separate/VB
from/IN
one/CD
another/DT
and/CC
exploit/VBP
new/JJ
environments/NNS
for/IN
species/NNS
proliferation/NN
./.
====================
The/DT
purpose/NN
of/IN
this/DT
article/NN
is/VBZ
to/TO
analyze/VB
MBPT/NN
sequences/NNS
derived/VBN
from/IN
infectious/JJ
and/CC
non/JJ
infectious/JJ
microbial/JJ
organisms/NNS
using/VBG
a/DT
variety/NN
of/IN
bioinformatic/JJ
tools/NNS
./.
====================
Here/RB
,/,
we/PRP
hypothesize/VBP
that/IN
the/DT
sequence/NN
and/CC
the/DT
function/NN
of/IN
MBPT/NN
differs/VBZ
significantly/RB
between/IN
the/DT
two/CD
groups/NNS
./.
====================
The/DT
differences/NNS
in/IN
the/DT
protein/NN
sequence/NN
may/MD
play/VB
a/DT
decisive/JJ
role/NN
in/IN
defining/VBG
the/DT
pathogenicity/NN
of/IN
a/DT
microbe/NN
./.
====================
The/DT
sequences/NNS
for/IN
analysis/NN
were/VBD
obtained/VBN
from/IN
the/DT
NCBI/NN
website/JJ
(/(
http/NN
:/:
//www/JJ
./.
====================
ncbi/RB
./.
====================
nlm/RB
./.
====================
nih/DT
./.
====================
gov//DT
)/)
./.
====================
Thirty/DT
one/CD
sequences/NNS
were/VBD
carefully/RB
selected/VBN
based/VBN
on/IN
their/PRP$
size/NN
,/,
function/NN
,/,
and/CC
organism/NN
origin/NN
./.
====================
The/DT
selected/VBN
sequences/NNS
include/VBP
fifteen/CD
sequences/NNS
from/IN
bacterial/JJ
species/NNS
(/(
fourteen/CD
gamma/NN
proteobacteria/NN
and/CC
one/CD
alpha/NN
proteobacteria/NN
)/)
that/WDT
are/VBP
known/VBN
to/TO
be/VB
infectious/JJ
in/IN
humans/NNS
and/CC
sixteen/CD
sequences/NNS
from/IN
non/JJ
infectious/JJ
bacterial/JJ
species/NNS
(/(
nine/CD
alpha/NN
proteobacteria/NN
and/CC
six/CD
beta/NN
proteobacteria/NNS
)/)
./.
====================
MBPT/NN
was/VBD
chosen/NN
because/IN
of/IN
its/PRP$
occurrence/NN
in/IN
a/DT
number/NN
of/IN
non/JJ
infectious/JJ
as/IN
well/RB
as/IN
infectious/JJ
bacteria/NNS
from/IN
a/DT
wide/JJ
variety/NN
of/IN
environments/NNS
./.
====================
The/DT
bacteria/NNS
were/VBD
selected/VBN
based/VBN
on/IN
the/DT
severity/NN
of/IN
pathogenicity/NN
as/IN
the/DT
most/JJS
infectious/JJ
diseases/NNS
were/VBD
found/VBN
in/IN
the/DT
gamma/NN
proteobacteria/NN
family/NN
and/CC
represented/VBD
in/IN
the/DT
infectious/JJ
bacteria/NNS
chosen/NN
for/IN
analysis/NN
./.
====================
Motifs/NNS
were/VBD
identified/VBN
using/VBG
the/DT
MEME/NN
Motif/NNP
Discovery/NN
Tool/NN
at/IN
the/DT
default/NN
settings/NNS
except/IN
for/IN
increasing/VBG
the/DT
maximum/NN
number/NN
of/IN
motifs/NNS
to/TO
ten/CD
(/(
Bailey/NNP
et/FW
al./FW
,/,
2006/CD
)/)
./.
====================
The/DT
identification/NN
of/IN
similar/JJ
motifs/NNS
as/IN
well/RB
as/IN
the/DT
analysis/NN
of/IN
the/DT
phylogenic/JJ
tree/CD
aided/VBD
in/IN
the/DT
construction/NN
of/IN
the/DT
dot/JJ
plots/NNS
to/TO
further/RBR
analyze/VB
the/DT
position/NN
of/IN
specific/JJ
amino/NN
acid/NN
motifs/NNS
in/IN
the/DT
selected/VBN
protein/NN
sequences/NNS
./.
====================
Dot/RB
matrices/NNS
were/VBD
constructed/VBN
using/VBG
the/DT
dotmatcher/JJ
program/NN
in/IN
which/WDT
the/DT
chosen/NN
sequences/NNS
were/VBD
compared/VBN
to/TO
show/VB
similarity/NN
among/IN
the/DT
infectious/JJ
bacteria/NNS
and/CC
the/DT
non/JJ
infectious/JJ
bacteria/NNS
(/(
Landes/NNS
et/FW
al./FW
,/,
1998/CD
)/)
./.
====================
Similarity/NN
between/IN
the/DT
sequences/NNS
was/VBD
assessed/VBN
by/IN
showing/VBG
likeness/IN
through/IN
diagonal/JJ
fragments/NNS
in/IN
which/WDT
a/DT
straight/JJ
diagonal/JJ
line/NN
exemplifies/VBZ
a/DT
high/JJ
degree/NN
of/IN
similarity/NN
where/WRB
as/IN
scattered/VBN
diagonal/JJ
fragments/NNS
illustrate/VBP
points/NNS
of/IN
difference/NN
between/IN
the/DT
compared/VBN
protein/NN
sequences/NNS
./.
====================
The/DT
sequences/NNS
were/VBD
assessed/VBN
in/IN
the/DT
dot/JJ
matcher/RB
program/NN
using/VBG
a/DT
distance/NN
matrix/NN
,/,
data/NNS
matrix/VBP
,/,
and/CC
a/DT
chisquared/JJ
analysis/NN
to/TO
solely/RB
project/VB
the/DT
diagonal/JJ
fragments/NNS
of/IN
similarity/NN
between/IN
the/DT
axes/NNS
of/IN
the/DT
graph/NN
./.
====================
Dotplot/RB
comparisons/NNS
using/VBG
the/DT
dotmatcher/JJ
program/NN
with/IN
a/DT
window/JJ
size/NN
of/IN
10/CD
and/CC
a/DT
threshold/JJ
of/IN
23/CD
were/VBD
performed/VBN
in/IN
order/NN
to/TO
examine/VB
the/DT
similarities/NNS
between/IN
two/CD
sequences/NNS
of/IN
infectious/JJ
bacteria/NNS
,/,
noninfectious/JJ
bacteria/NNS
as/IN
well/RB
as/IN
between/IN
infectious/JJ
and/CC
noninfectious/JJ
bacteria/NNS
./.
====================
Further/RB
analysis/NN
was/VBD
done/VBN
to/TO
exemplify/VB
the/DT
differences/NNS
between/IN
pathogenic/JJ
and/CC
non/JJ
pathogenic/JJ
bacteria/NNS
and/CC
to/TO
isolate/VB
and/CC
evaluate/VBP
the/DT
subtle/JJ
differences/NNS
between/IN
the/DT
bacteria/NNS
sequences/NNS
./.
====================
Our/PRP$
sequences/NNS
were/VBD
aligned/VBN
using/VBG
Clustal/JJ
X/NN
(/(
Thompson/NN
et/FW
al./FW
,/,
1997/CD
)/)
./.
====================
The/DT
phylogenic/JJ
tree/CD
was/VBD
constructed/VBN
using/VBG
the/DT
neighbor-joining/JJ
method/NN
from/IN
the/DT
sequence/NN
alignment/NN
using/VBG
PHYLIP/NN
(/(
Felsenstein/NN
,/,
1989/CD
)/)
./.
====================
The/DT
“/NN
Bootstrapping/VBG
”/CD
method/NN
was/VBD
performed/VBN
on/IN
the/DT
phylogenic/JJ
tree/CD
to/TO
assure/VB
the/DT
position/NN
of/IN
the/DT
clades/NNS
as/IN
well/RB
as/IN
presenting/VBG
evolutionary/JJ
relationships/NNS
between/IN
the/DT
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
The/DT
tree/JJ
was/VBD
then/RB
viewed/VBD
in/IN
TREEVIEW/NN
for/IN
further/JJ
evaluation/NN
of/IN
the/DT
selected/VBN
sequences/NNS
(/(
Page/NN
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
When/WRB
analyzing/VBG
the/DT
MBPT/NN
motifs/NNS
of/IN
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
it/PRP
becomes/VBZ
apparent/JJ
that/IN
there/EX
are/VBP
several/JJ
distinct/JJ
differences/NNS
between/IN
MBPT/NN
in/IN
infectious/JJ
versus/CC
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
The/DT
infectious/JJ
bacteria/NNS
share/VBP
motifs/NNS
5/CD
and/CC
6/CD
while/IN
the/DT
non/JJ
infectious/JJ
bacteria/NNS
share/VBP
domain/NN
9/CD
(/(
Fig/NN
./.
====================
2/CD
)/)
./.
====================
Motif/NN
5/CD
is/VBZ
present/JJ
in/IN
sequences/NNS
1/CD
(/(
Shewanella/NN
sp/NN
./.
====================
W3-18-1/NN
)/)
through/IN
10/CD
(/(
Yersinia/NN
pseudotuberculosis/NN
PB1/＋/NN
)/)
as/IN
well/RB
as/IN
sequence/NN
12/CD
(/(
Haemophilus/NN
influenza/NN
PittGG/NN
)/)
through/IN
14/CD
(/(
Pseudomonas/NN
aeruginosa/NN
PA7/NN
)/)
which/WDT
are/VBP
all/DT
members/NNS
of/IN
the/DT
gamma/NN
proteobacteria/NN
family/NN
./.
====================
Motif/DT
5/CD
is/VBZ
not/RB
present/JJ
in/IN
the/DT
sequences/NNS
of/IN
11/CD
(/(
Haemophilus/NNP
influenza/NN
PittEE/NN
)/)
from/IN
the/DT
gamma/NN
proteobacteria/NN
family/NN
and/CC
15/CD
(/(
Phenylobacterium/NN
zucineum/NN
HLK1/NN
)/)
from/IN
the/DT
alpha/NN
proteobacteria/NN
family/NN
and/CC
is/VBZ
also/RB
missing/VBG
from/IN
the/DT
non/JJ
infectious/JJ
bacteria/NNS
group/NN
marked/JJ
with/IN
an/DT
(/(
*/LS
)/)
./.
====================
Motif/DT
9/CD
is/VBZ
present/JJ
in/IN
sequences/NNS
11/CD
and/CC
15/CD
as/IN
well/RB
as/IN
all/DT
of/IN
the/DT
non/JJ
infectious/JJ
bacteria/NNS
*16/CD
(/(
Oligotropha/NN
carboxidovorans/NNS
OM5/NN
)/)
through/IN
*31/CD
(/(
Ralstonia/NN
metallidurans/NNS
CH34/NN
)/)
with/IN
the/DT
exception/NN
of/IN
*25/CD
(/(
Azoarcus/FW
sp/NN
./.
====================
BH72/NN
)/)
./.
====================
Motif/DT
6/CD
is/VBZ
in/IN
all/DT
of/IN
the/DT
infectious/JJ
bacteria/NNS
except/IN
for/IN
1/CD
(/(
Shewanella/NN
sp/NN
./.
====================
W3181/CD
)/)
and/CC
15/CD
(/(
Phenylobacterium/NN
zucineum/NN
HLK1/NN
)/)
as/IN
well/RB
as/IN
being/VBG
absent/JJ
in/IN
all/DT
of/IN
the/DT
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
Motif/DT
8/CD
exists/VBZ
only/RB
in/IN
the/DT
bacteria/NNS
from/IN
two/CD
different/JJ
genuses/NNS
:/:
Shigella/NN
and/CC
Escherichia/FW
as/IN
these/DT
two/CD
bacteria/NNS
are/VBP
closely/RB
related/JJ
./.
====================
The/DT
dot/JJ
plots/NNS
show/VBP
the/DT
degree/NN
of/IN
similarity/NN
between/IN
specified/VBN
protein/NN
sequences/NNS
of/IN
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
(/(
Fig/NN
./.
====================
3/CD
)/)
./.
====================
The/DT
dot/JJ
plots/NNS
comparing/VBG
non/JJ
infectious/JJ
to/TO
infectious/JJ
strains/NNS
of/IN
bacteria/NNS
enable/VBP
specific/JJ
points/NNS
of/IN
the/DT
protein/NN
structure/NN
to/TO
be/VB
identified/VBN
and/CC
analyzed/VBD
./.
====================
The/DT
data/NNS
produced/VBD
by/IN
the/DT
dot/JJ
plots/NNS
reinforces/VBZ
the/DT
minute/JJ
differences/NNS
found/VBN
between/IN
specified/VBN
protein/NN
sequences/NNS
and/CC
can/MD
be/VB
used/VBN
for/IN
further/JJ
analysis/NN
of/IN
different/JJ
amino/NN
acid/NN
residues/NNS
among/IN
two/CD
different/JJ
species/NNS
of/IN
bacteria/NNS
./.
====================
The/DT
dot/JJ
plots/NNS
comparing/VBG
non/JJ
infectious/JJ
to/TO
infectious/JJ
bacteria/NNS
underline/JJ
the/DT
motifs/NNS
that/WDT
are/VBP
conserved/VBN
between/IN
the/DT
two/CD
types/NNS
of/IN
bacteria/NNS
such/JJ
as/IN
motifs/NNS
1/CD
,/,
2/CD
,/,
3/CD
,/,
4/CD
,/,
and/CC
7/CD
while/IN
reinforcing/VBG
the/DT
motifs/NNS
within/IN
specific/JJ
domains/NNS
that/IN
are/VBP
not/RB
shared/VBN
:/:
6/CD
,/,
5/CD
,/,
9/CD
,/,
and/CC
8/CD
./.
====================
As/IN
hypothesized/VBN
,/,
the/DT
phylogenic/JJ
tree/CD
analysis/NN
identified/VBD
two/CD
distinct/JJ
clades/NNS
:/:
one/CD
aligning/VBG
the/DT
infectious/JJ
bacteria/NNS
and/CC
the/DT
other/JJ
aligning/JJ
the/DT
non/JJ
infectious/JJ
bacteria/NNS
(/(
Fig/NN
./.
====================
4/CD
)/)
./.
====================
The/DT
non/JJ
infectious/JJ
bacteria/NNS
are/VBP
divided/VBN
between/IN
alpha/NN
and/CC
beta/NN
classes/NNS
of/IN
proteobacteria/NN
as/IN
al/JJ
most/JJS
all/DT
of/IN
the/DT
infectious/JJ
bacteria/NNS
are/VBP
in/IN
the/DT
gamma/NN
proteobacteria/NN
family/NN
except/IN
for/IN
Phenylobacterium/NN
zucineum/NN
HLK1/NN
,/,
an/DT
alpha/NN
proteobacteria/NN
./.
====================
The/DT
lower/JJR
scores/VBZ
of/IN
some/DT
of/IN
the/DT
infectious/JJ
bacteria/NNS
like/IN
Shigella/NN
dysenteriae/FW
Sd197/NN
,/,
Pseudomonas/NN
aeruginosa/NN
PA7/NN
,/,
and/CC
Phenylobacterium/NN
zucineum/NN
HLK1/NN
show/VBP
some/DT
evolutional/JJ
and/CC
sequential/JJ
distance/NN
between/IN
these/DT
species/NNS
of/IN
bacteria/NNS
and/CC
the/DT
other/JJ
species/NNS
of/IN
infectious/JJ
bacteria/NNS
yet/RB
are/VBP
able/JJ
to/TO
remain/VB
within/IN
the/DT
infectious/JJ
grouping/VBG
./.
====================
The/DT
bacteria/NNS
Rhodopseudomonas/NN
palustris/NNS
CGA009/CD
exhibits/VBZ
some/DT
phylogenetic/JJ
distance/NN
by/IN
its/PRP$
lower/JJR
score/RB
while/IN
remaining/VBG
in/IN
the/DT
non/JJ
infectious/JJ
group/NN
of/IN
bacteria/NNS
./.
====================
The/DT
evolutionary/JJ
distance/NN
of/IN
bacteria/NNS
in/IN
the/DT
phylogenic/JJ
the/DT
tree/JJ
shows/VBZ
adaptation/NN
of/IN
these/DT
bacteria/NNS
to/TO
new/JJ
niches/NNS
that/DT
others/NNS
are/VBP
not/RB
able/JJ
to/TO
propagate/VB
in/IN
and/CC
these/DT
differences/NNS
become/IN
apparent/JJ
in/IN
the/DT
sequence/NN
of/IN
MBPT/NN
for/IN
the/DT
particular/JJ
bacteria/NNS
./.
====================
The/DT
phylogenic/JJ
analysis/NN
of/IN
MBPT/NN
shows/VBZ
a/DT
definite/JJ
separation/NN
in/IN
the/DT
protein/NN
sequence/NN
between/IN
a/DT
variety/NN
of/IN
in/FW
fectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
The/DT
formation/NN
of/IN
the/DT
phylogenic/JJ
tree/CD
shows/VBZ
the/DT
possibility/NN
that/IN
infectious/JJ
bacteria/NNS
may/MD
have/VB
evolved/VBN
from/IN
non/JJ
infectious/JJ
bacteria/NNS
due/JJ
to/TO
the/DT
separation/NN
of/IN
the/DT
two/CD
types/NNS
of/IN
bacteria/NNS
(/(
Maurelli/NN
,/,
2006/CD
)/)
./.
====================
An/DT
analysis/NN
of/IN
the/DT
bacterial/JJ
motifs/NNS
shows/VBZ
particular/JJ
differences/NNS
among/IN
the/DT
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
including/VBG
the/DT
presence/NN
of/IN
motifs/NNS
5/CD
,/,
6/CD
,/,
and/CC
8/CD
in/IN
the/DT
infectious/JJ
bacteria/NNS
./.
====================
Absence/NN
and/CC
movement/JJ
of/IN
motifs/NNS
9/CD
and/CC
10/CD
are/VBP
noted/VBN
among/IN
the/DT
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
and/CC
may/MD
also/RB
glean/JJ
more/RBR
insight/NN
into/IN
the/DT
pathogenicity/NN
of/IN
bacteria/NNS
./.
====================
Motifs/NNS
1/CD
,/,
2/CD
,/,
and/CC
3/CD
are/VBP
recognized/VBN
as/IN
being/VBG
structurally/RB
required/VBN
by/IN
all/DT
of/IN
the/DT
bacteria/NNS
./.
====================
The/DT
movement/JJ
of/IN
motif/NN
10/CD
is/VBZ
evident/JJ
in/IN
our/PRP$
motif/NN
analysis/NN
and/CC
further/RB
investigation/NN
may/MD
give/VB
us/PRP
a/DT
clue/NN
as/IN
to/TO
why/WRB
it/PRP
is/VBZ
prominently/RB
in/IN
one/CD
position/NN
in/IN
the/DT
infectious/JJ
bacteria/NNS
and/CC
another/DT
in/IN
the/DT
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
The/DT
Phenylobacterium/NN
zucineum/NN
HLK1/NN
bacteria/NNS
not/RB
only/RB
lacks/VBZ
the/DT
traditional/JJ
motifs/NNS
for/IN
infection/NN
but/CC
also/RB
has/VBZ
motif/NN
10/CD
arranged/JJ
on/IN
the/DT
outside/JJ
of/IN
the/DT
protein/NN
sequence/NN
in/IN
mimicry/NN
of/IN
a/DT
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
The/DT
fact/NN
that/IN
an/DT
infectious/JJ
bacteria/NNS
can/MD
imitate/VB
a/DT
non/JJ
infectious/JJ
bacteria/NNS
is/VBZ
concerning/VBG
but/CC
the/DT
only/RB
clear/JJ
anomaly/RB
in/IN
this/DT
study/NN
./.
====================
The/DT
changes/NNS
between/IN
specific/JJ
amino/NN
acids/NNS
in/IN
the/DT
MBPT/NN
sequences/NNS
reinforces/VBZ
evolutionary/JJ
changes/NNS
between/IN
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
which/WDT
enable/VBP
the/DT
infectious/JJ
bacteria/NNS
to/TO
take/VB
advantage/NN
of/IN
new/JJ
roles/NNS
for/IN
further/JJ
propagation/NN
of/IN
their/PRP$
species/NNS
that/IN
the/DT
non/JJ
infectious/JJ
bacteria/NNS
are/VBP
unable/JJ
to/TO
assume/VB
./.
====================
Comparison/NN
of/IN
motif/NN
organization/NN
,/,
amino/NN
acid/NN
sequences/NNS
,/,
dot/RB
plots/NNS
and/CC
the/DT
phylogenic/JJ
tree/CD
can/MD
isolate/VB
particular/JJ
points/NNS
of/IN
divergence/NN
between/IN
the/DT
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacterial/JJ
sequences/NNS
that/WDT
may/MD
be/VB
exploited/VBN
as/IN
a/DT
new/JJ
source/NN
to/TO
fight/CD
infection/NN
./.
====================
Further/RB
sequential/JJ
,/,
biochemical/JJ
,/,
and/CC
evolutionary/JJ
analysis/NN
may/MD
continue/VB
to/TO
show/VB
details/VBZ
found/VBN
in/IN
the/DT
analysis/NN
presented/VBN
here/RB
for/IN
a/DT
novel/JJ
,/,
applicable/JJ
treatment/NN
to/TO
a/DT
wide/JJ
variety/NN
of/IN
infectious/JJ
bacteria/NNS
./.
====================
The/DT
bioinformatic/JJ
analysis/NN
of/IN
Monofunctional/JJ
Biosynthetic/JJ
Peptidoglycan/NN
Transglycosylase/NN
presented/VBN
here/RB
shows/VBZ
a/DT
clear/JJ
distinction/NN
in/IN
the/DT
protein/NN
sequence/NN
between/IN
the/DT
infectious/JJ
and/CC
non/JJ
infectious/JJ
bacteria/NNS
./.
====================
Further/RB
analysis/NN
can/MD
be/VB
done/VBN
to/TO
create/VB
a/DT
viable/JJ
application/NN
to/TO
fight/CD
a/DT
multitude/JJ
of/IN
bacterial/JJ
infection/NN
using/VBG
MBPT/NN
./.
====================
An/DT
analysis/NN
of/IN
the/DT
role/NN
of/IN
MBPT/NN
in/IN
cell/NN
division/NN
may/MD
further/RBR
shed/VBD
some/DT
light/JJ
on/IN
its/PRP$
cellular/JJ
role/NN
as/IN
well/RB
as/IN
its/PRP$
ability/NN
to/TO
evade/VB
antibiotics/NNS
,/,
like/IN
β-lactam/JJ
,/,
which/WDT
inhibit/VBP
the/DT
bifunctional/JJ
transpeptidase/NN
activity/NN
of/IN
PBP/NN
(/(
Di/NNP
Berardino/NN
et/FW
al./FW
,/,
1996/CD
)/)
./.
====================
A/DT
comparison/NN
of/IN
the/DT
monofunctional/JJ
and/CC
bifunctional/JJ
protein/NN
sequences/NNS
may/MD
produce/VB
further/RBR
insight/NN
in/IN
the/DT
pathogenicity/NN
of/IN
these/DT
cell/NN
wall/NN
building/VBG
proteins/NNS
./.
====================
The/DT
analysis/NN
presented/VBD
here/RB
provides/VBZ
a/DT
basis/NN
on/IN
which/WDT
further/RB
research/NN
for/IN
utilizing/VBG
MBPT/NN
as/IN
a/DT
new/JJ
target/NN
for/IN
inhibiting/VBG
bacterial/JJ
infection/NN
can/MD
be/VB
built/JJ
upon/IN
./.
====================
